Search Results 501-510 of 16848 for Antagonist

  1. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  2. Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer - Mayo Clinic

    No more than 7 days of prior use of mixed opioid agonist/opioid antagonists or other opioid antagonists within 4 weeks before registration. Patients should ...

  3. A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification - Mayo Clinic

    Nitrate use or α-antagonist medication use within 24 hours; Systolic blood pressure <110 mm Hg; Mean systemic arterial pressure <75 mm Hg; Severe mitral or ...

  4. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

    Patients requiring therapeutic anticoagulation with warfarin or another Vitamin K antagonist * Current treatment with strong cytochrome P450 (CYP) 3A4 ...

  5. Personality disorders - Symptoms and causes - Mayo Clinic

    A person with this mental health condition thinks, acts and behaves in a rigid pattern that's not healthy. It's hard to understand and relate to others.

  6. Hematology - Clinical trials

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

  7. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    Requires or receiving anticoagulation with warfarin or equivalent vitamin K antagonists (e.g. phenprocoumon) within 7 days of first dose of study drug and while ...

  8. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    Patients previously treated with MDM2 antagonist therapies or patients receiving interferon-alpha, anagrelide, or ruxolitinib within 28 days or 5 half-lives ...

  9. Publications - Karissa N. Arca, M.D. - Mayo Clinic

    Calcitonin Gene-Related Peptide Antagonists for the Prevention of Migraine: Highlights From Pivotal Studies and the Clinical Relevance of This New Drug Class.

  10. Assessing the Efficacy of Steroid Treatment of Achalasia - Mayo Clinic

    Use of medications that might affect LES pressure such as anticholinergics or calcium channel antagonists; Symptom duration greater than 2 years; Inability to ...